Review and revision of guidelines for ovarian cancer treatment in Japan

Junzo Kigawa, Hidetaka Katabuchi, Nobuo Yaegashi

研究成果: Article査読

2 被引用数 (Scopus)

抄録

A survey of members of the Japan Society of Gynecologic Oncology revealed that 93% of the members use the present Guideline for Ovarian Cancer Treatment in practice. There is an international consensus about first-line treatment for ovarian cancer. In contrast, the treatment for sex-cord stromal tumor, which is rare, and recurrent cancer are not standardized. In addition, management for borderline malignant tumor has been controversial. The new revision incorporates a new chapter regarding these matters. The revised Guideline may be more useful. We hope that re-examination and future revisions will be made to continually update the Guideline.

本文言語English
ページ(範囲)617-619
ページ数3
ジャーナルJapanese Journal of Cancer and Chemotherapy
37
4
出版ステータスPublished - 2010 4 6

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「Review and revision of guidelines for ovarian cancer treatment in Japan」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル